Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are suspected of having bladder cancer and are already scheduled to have a surgical procedure to remove a bladder tumour (called a transurethral resection).
- People who agree to provide a biological sample (such as tissue or blood) for research purposes.
- People who are willing to follow the study rules and requirements throughout the trial.
- People who have voluntarily signed the consent form agreeing to take part in the study.
- People who are 18 years of age or older.
Who may not be able to join:
- People who do not agree to take part in this study.
- People who are considered vulnerable participants (confirm with trial site for the specific definition used).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Won Sik Ham, Department of Urology and Urological Science Institute, Yonsei University College of Medicine Seoul, Republic of Korea
Phone: 02-2228-2310
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of responder to neoadjuvant chemotherapy by genetic and molecular profiles
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.